Researchers find genetic variation that lowers effect of cholesterol drugs

A U.S. study of 1,500 people treated with statins found those who had a common genetic variation affecting how they synthesize cholesterol had a total cholesterol reduction that was 22% smaller than others after six months. The researchers said their findings could result in pharmacogenetic screening that would help doctors prescribe the right dosage of statin medicine for their patients.

View Full Article in:

Reuters · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA